MOLECULAR CANCER THERAPEUTICS | SMALL MOLECULE THERAPEUTICS SAR439859, a Novel Selective Estrogen Receptor Degrader (SERD), Demonstrates Effective and Broad Antitumor Activity in Wild-Type and Mutant ER-Positive Breast Cancer Models
暂无分享,去创建一个
Joon Sang Lee | L. Debussche | M. Levit | Zhuyan Guo | J. Pollard | D. Hoffmann | Fangxian Sun | L. Besret | H. Cao | V. Certal | M. Tabart | Y. El-Ahmad | M. Koundinya | D. Bangari | Jane Cheng | F. Halley | Fabienne Thompson | A. Caron | A. Hebert | R. Arrebola | M. Bouaboula | Jessica Mcmanus | P. Abecassis | L. Schio | Maysoun Shomali | A. Courjaud | GaryMcCort | Bruno Filoche-Romm | Hongcheng | CarlosGarcia-Echeverria | Jack Pollard | Laurent Schio | Dietmar Hoffmann